MW-C1

N/A

Report date: 2025/07/09 16:21:33

Base Information

Drug NameMW-C1
Drug Alias NameMW-C1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Claudin 1
TargetsClaudin 1
Therapy Area/IndicationsSolid tumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Squamous Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMabwell (Shanghai) Bioscience Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMabwell (Shanghai) Bioscience Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Squamous Cell +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A